Evidence map›Paper›PMID 33969153›Full record

ArticleVirusdisease2021

A cross sectional study of the risk factors of hepatitis C infection in North Egypt.

Soad S Mandoh, Kholoud Ayman, Ahmed Elbardakheny, Hala Raaft, Ahmed A Ibrahim, Rasha Alsaeed Alshaikh, Fotouh R Mansour

Abstract read
In one paragraph

Article in Virusdisease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Soad S MandohHCV Fighters, Faculty of Pharmacy, Tanta University, Tanta, 31111 Egypt.
Kholoud AymanHCV Fighters, Faculty of Pharmacy, Tanta University, Tanta, 31111 Egypt.
Ahmed ElbardakhenyHCV Fighters, Faculty of Pharmacy, Tanta University, Tanta, 31111 Egypt.
Hala RaaftHCV Fighters, Faculty of Pharmacy, Tanta University, Tanta, 31111 Egypt.
Ahmed A IbrahimHCV Fighters, Faculty of Pharmacy, Tanta University, Tanta, 31111 Egypt.
Rasha Alsaeed AlshaikhDepartment of Pharmaceutical Technology, Faculty of Pharmacy, Tanta University, Tanta, 31111 Egypt.
Fotouh R MansourDepartment of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Tanta University, Tanta, 31111 Egypt.ORCID 0000-0003-0847-4035

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatitis C is a viral infection that has been declared as a global health problem by the World Health Organization. Egypt has the highest prevalence of hepatitis C virus (HCV) which results in a high morbidity and mortality from chronic liver disease, cirrhosis, and even hepatocellular carcinoma. Cities have lower rates of infection than rural areas. Studies about the abnormally high prevalence of HCV in Egypt ascribed that to the governmental campaign to treat Schistosoma. However, these treatment campaigns have stopped more than 35 years ago, which means that some other modes of transmission must have been involved. The objective of this work is to study the main reasons of HCV prevalence in the Egyptian Delta valley. A questionnaire-based study was conducted by members of the HCV Fighters project. Responses were collected from 949 volunteers (451 HCV patients and 498 healthy volunteers as control). The data were analyzed using SPSS version 19.0. The two-sample proportion test was used for statistical comparison between groups. The most probable risk factors of HCV transmission in Egypt included regular visits to dental clinics (55.2%), previous surgical operations (54.4%), former blood transfusion (52%), intrafamilial HCV infection (45.9%) and history of bilharzial infection (44.3%). Increasing public awareness about modes of transmission and risk factors of HCV infection is a must, especially within family members of HCV patients. Strict commitment to proper medical care precautions by health care practitioners is required.

Indexed as

Dental clinicsEgyptHepatitis C virusPrevalenceRisk factorsSurgical operations

Identifiers

PMID33969153
PMCPMC8093146

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.